Bone Material Strength Index Is Low in Patients With Cushing's Syndrome Even After Long-term Remission
The Journal of Clinical Endocrinology & Metabolism · 15.07.2025 · 110 (8) · e2691-e2699
DOI: 10.1210/clinem/dgae799 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 20.11.2024. Verfasst von Manuela Schoeb und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Bone Quality, Department of Medicine, Division of Endocrinology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands. Hauptthemen laut MEDLINE: Cushing Syndrome, Bone Density. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: European Calcified Tissue Society, Clinical Research Fellowship and an Exchange in Endocrinology, Grant of the European Union of Medical Specialists.
Abstract (Originalsprache)
Objective
Hypercortisolism in endogenous Cushing's syndrome (CS) results in decreased bone mineral density (BMD) and increased fracture risk. Although after remission BMD improves, the fracture rate remains elevated, suggesting that BMD may not adequately reflect fracture risk in this group. The aim was to evaluate bone material properties, another component of bone quality, using impact microindentation in patients with CS in remission.
Methods
Cross-sectional study in 60 CS patients and 60 age-, sex-, and BMD-matched controls at a tertiary referral center between 2019 and 2021. Bone material strength index (BMSi) was measured by impact microindentation using the OsteoProbe® device at the tibia. In addition, laboratory investigation, BMD, and vertebral fracture assessment were performed.
Results
By design, patients and controls were comparable for age (median age 56.5 years), sex (48 women), and BMD at the lumbar spine and femoral neck. They were also comparable regarding the number of fragility fractures (21 vs 27, P = .22). The median time of remission in patients was 6 years (range 1 to 41). Despite comparable BMD, BMSi was significantly lower in CS patients compared to controls (76.2 ± 6.7 vs 80.5 ± 4.9, P < .001). In CS patients, BMSi was negatively correlated with body mass index (r = −0.354, P = .01) but not related to the presence of fracture, physiological hydrocortisone replacement use, other pituitary insufficiencies, or time since remission.
Conclusion
Bone material properties remain altered in patients with endogenous CS, even after long-term remission. These abnormalities, known to be associated with fractures in other populations, may play a role in the persistent bone fragility of steroid excess.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Bone Quality, Department of Medicine, Division of Endocrinology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
- Center for Endocrine Tumors Leiden, Department of Medicine, Division of Endocrinology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
- Department of Endocrinology & Metabolism, Amsterdam UMC Location University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
- Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam UMC Location University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
ORCID-Profile: Manuela Schoeb, Michiel F Nijhoff, Alberto M Pereira, Natasha M Appelman-Dijkstra
Förderung
- European Calcified Tissue Society
- Clinical Research Fellowship and an Exchange in Endocrinology
- Grant of the European Union of Medical Specialists
Zitieren
APA
Schoeb, M., Sintenie, P. J. C., Bakker, L. E. H., Biermasz, N. R., van Haalen, F. M., Nijhoff, M. F., de Vries, F., Winter, E. M., Pereira, A. M., & Appelman-Dijkstra, N. M. (2025). Bone Material Strength Index Is Low in Patients With Cushing's Syndrome Even After Long-term Remission. The Journal of Clinical Endocrinology & Metabolism, 110(8), e2691-e2699. https://doi.org/10.1210/clinem/dgae799
Vancouver
Schoeb M, Sintenie PJC, Bakker LEH, Biermasz NR, van Haalen FM, Nijhoff MF, et al. Bone Material Strength Index Is Low in Patients With Cushing's Syndrome Even After Long-term Remission. The Journal of Clinical Endocrinology & Metabolism. 2025;110(8):e2691-e2699. doi:10.1210/clinem/dgae799
BibTeX
@article{Schoeb2025,
author = {Schoeb, Manuela and Sintenie, Paula J C and Bakker, Leontine E H and Biermasz, Nienke R and van Haalen, Femke M and Nijhoff, Michiel F and de Vries, Friso and Winter, Elizabeth M and Pereira, Alberto M and Appelman-Dijkstra, Natasha M},
title = {Bone Material Strength Index Is Low in Patients With Cushing's Syndrome Even After Long-term Remission},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
volume = {110},
number = {8},
pages = {e2691--e2699},
doi = {10.1210/clinem/dgae799}
}
EUVIMED